Company: AIP
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001667011-25-000022
Chunk: 352

Company: Arteris, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 2
Chunk 352
---
 increased, $1.0 million, or 9%, to $11.9 million for the three months ended March 31, 2025 from $10.8 million for the three months ended March 31, 2024. The increase in R&D expenses was due to higher employee-related costs of $0.7 million, including stock-based compensation expense. We also received lower grants of $0.2 million by our subsidiary in France for R&D projects and incurred higher professional fees of $0.1 million.

Sales and marketing expenses

S&M expenses increased $1.1 million or 20%, to $6.5 million for the three months ended March 31, 2025 from $5.5 million for the three months ended March 31, 2024. The increase in S&M expenses was primarily due to higher employee-related costs of $0.8 million mainly driven by increased headcount to support growth of our business, including stock-based compensation expense. 

General and administrative expenses

G&A expenses remained relatively flat for the three months ended March 31, 2025 compared to the three months ended March 31, 2024.

Interest expense

Three Months Ended March 31,Change20252024$%(dollars in thousands)Interest expense$(48)$(76)$28 (37)%

Interest expense remained relatively flat for the three months ended March 31, 2025 compared to the three months ended March 31, 2024.

Other income (expense), net

Three Months Ended March 31,Change20252024$%(dollars in thousands)Other income (expense), net$718 $936 $(218)(23)%

Other income (expense), net decreased $0.2 million, or 23%, to $0.7 million for the three months ended March 31, 2025, from $0.9 million for the three months ended March 31, 2024. The decrease in interest and other income (expense), net was primarily related to foreign currency exchange, as well as lower interest rates on cash balances and lower interest income earned on our available-for-sale investments.

28

Loss from equity method investment

Three Months Ended March 31,Change20252024$%(dollars in thousands)Loss from equity method investment$815 $759 $56 7 %

Loss from equity method investment remained relatively flat for the three months ended March 31, 2025 compared to the three months ended